2025 Merkin Prize in Biomedical Technology awarded to pioneers of CAR T-cell therapy
Broad Institute
MAY 21, 2025
Sadelain and Rivire also developed safe and reliable ways to produce these cells for use in patients. In 2007, Sadelain and Rivire treated their first patient with leukemia, and in 2009, published details on how they manufactured personalized CAR T cells to treat patients with aggressive leukemia.
Let's personalize your content